Diseases by global value and by relative value in low and central low incomes of countries. Notes: The illustration appearance preselected diseases and conditions according to global healthy years of life lost and the relative weight of each illness or condition in developing countries. If the relative weight is 2, that indicates that illness is twice as probably for a lost healthy year of life preselected after the coincidence in with low the income countries responsible its as in with high income the countries. All data withdrawed from the World Health Organization (2004). Healthy years of life into the lower income countries and into 2% from lost healthy years of life in the high income countries a relative weight of 3rd diseases with high relatives to have a weight into the lower income countries are that probable to be neglected. Malaria is expressed the precedent of a very important illness, in its effect on global health, which heavily concentrated in with low the income countries. Generally, noncommunicable diseases have a relative weight close one.1 the positive relationship between incomes affected by those by an illness and the quantity of research taken up to pharmaceutical products for this illness empirically in a multiplicity of studies, including Lanjouw were confirmed and MacLeod (2005) and Lichtenberg (2005a). Predominating an illness in some developing countries was attributed to frequently poor food, water, and hygiene or entrance to the treatment and May an absence useful does not reflect pharmaceutical products. In such cases it knows factors differently than pharmaceutical its innovation, which must be addressed. However even if other solutions are possible, can it to situations also give, in those a pharmaceutical solution are you the most cost effective, if it were present. E.G. it knows 78 Aidan Hollis is simpler you to address the problem of malaria by a vaccine rather than by eliminating the vector of the illness, begins mosquitoI with a short examination of the neglected diseases. I define a neglected illness one, for those the additional dollar, which were spent on research, a relatively large increase effect on therapeutic results would have there. Drogenfirme, because of their obligations to the shareholders, invest in developing therapies for the diseases, which are based on the increase effect on profits. This means that neglected diseases those is expected to be unprofitable for the investment, in order despite the opportunity for improving the therapeutic results is. Other $200 million in the research into an already heavily investigated illness to invest can be useful, and froma profit perspective, can it the right thing be to do to; but it is probable that from the perspective of the maximization of the number and the quality of the human life on the planet, it could be more useful to spend the money on developing treatments on malaria. It is this direction, in which malaria neglected one „“illness is. In reality such diseases those, which are mainly predominant in with low the income countries, are natural. Table 4.1 points diseases according to the entire „disabilityadjusted life years “(healthy years of life) lost to each illness or to condition. (A healthy year of life is a standardised measure of results of health.) Some diseases are grouped together for comfort.